Cargando…

Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital

OBJECTIVE: To compare the efficacy and the period of use of tocilizumab and infliximab during treatment of rheumatoid arthritis patients. METHODS: The period of use of two biologics with different mechanisms of action were compared in treatment of rheumatoid arthritis patients. RESULTS: Both medicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golmia, Ricardo Prado, Scheinberg, Morton Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880388/ https://www.ncbi.nlm.nih.gov/pubmed/24488390 http://dx.doi.org/10.1590/S1679-45082013000400015

Ejemplares similares

Real life experience on the effect of Belimumab in patients with active systemic lupus
por: Scheinberg, Morton, et al.
Publicado: (2014)

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
por: Diep, Laetitia, et al.
Publicado: (2022)

Bone health in cerebral palsy and introduction of a novel therapy
por: Scheinberg, Morton Aaron, et al.
Publicado: (2015)

Comparison of thromboprophylaxis patterns in arthroplasty in public and private hospitals
por: Cortada, Aline Pinheiro dos Santos, et al.
Publicado: (2015)

Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review
por: Schmerling, Rafael A, et al.
Publicado: (2020)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
por: Berbert Ferreira, Rachel, et al.
Publicado: (2019)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study
por: Hilliquin, Pascal, et al.
Publicado: (2020)

Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab
por: Mori, Shunsuke, et al.
Publicado: (2011)

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market
por: Scheinberg, Morton Aaron, et al.
Publicado: (2018)

Retention rates of adalimumab, etanercept, and infliximab as first‐ or second‐line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France)
por: Soubrier, Martin, et al.
Publicado: (2018)

Effects of Long-Term Methotrexate, Infliximab, and Tocilizumab Administration on Bone Microarchitecture and Tendon Morphology in Healthy Wistar Rats
por: Poutoglidou, Frideriki, et al.
Publicado: (2021)

Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study
por: Mori, Shunsuke, et al.
Publicado: (2019)

Infliximab: 12 years of experience
por: Smolen, Josef S, et al.
Publicado: (2011)

Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
por: Scheinberg, Morton, et al.
Publicado: (2017)

Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023)

Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
por: Maximova, Natalia, et al.
Publicado: (2020)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Reactivation of Chagas-Mazza disease during treatment with infliximab
por: Vacas, Aldana Soledad, et al.
Publicado: (2017)

Tocilizumab for hospitalized patients with COVID-19
por: Afra, Kevin, et al.
Publicado: (2021)

Response of Fibroblastic Rheumatism to Infliximab
por: Romiti, Ricardo, et al.
Publicado: (2009)

The anxiety of nursing professionals during the COVID-19 pandemic period in a brazilian regional university hospital
por: Floriano, L., et al.
Publicado: (2021)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Strategies for talent engagement and retention of Brazilian Nursing professionals
por: Schlosser, Francine, et al.
Publicado: (2022)

Changes in mastectomy rates at a Brazilian public hospital over 20 years (1989 to 2008)
por: Balabram, Débora, et al.
Publicado: (2013)

The history of pulse therapy in lupus nephritis (1976–2016)
por: Scheinberg, Morton
Publicado: (2016)

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Teixeira, Fabio Vieira, et al.
Publicado: (2019)

Remicade(®) (infliximab): 20 years of contributions to science and medicine
por: Melsheimer, Richard, et al.
Publicado: (2019)

In-hospital mortality in patients with acute limb ischemia over a 12-year period in the Brazilian public health-care system
por: do Nascimento, João Henrique Fonseca, et al.
Publicado: (2022)

Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
por: Izumi, Keisuke, et al.
Publicado: (2015)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

THROMBOEMBOLIC AND BLEEDING EVENTS IN ICU PATIENTS WITH COVID-19: RESULTS FROM A BRAZILIAN TERTIARY HOSPITAL
por: Brandão, A.A.G.S., et al.
Publicado: (2020)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

Bolsonaro’s Brazilian Christofascism during the Easter period plagued by Covid-19
por: Py, Fábio
Publicado: (2020)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n894aumq7tfp3v2odfouk7k8bp